Distinguishing repeated polymerase chain reaction positivity from re-infections in COVID-19
Open Access
- 1 November 2021
- journal article
- research article
- Published by Wiley in Influenza and Other Respiratory Viruses
- Vol. 15 (6) , 742-749
Abstract
Background Possibility of reinfection with SARS-CoV-2 changes our view on herd immunity and vaccination and can impact worldwide quarantine policies. We performed real-time polymerase chain reaction (RT-PCR) follow-up studies on recovered patients to assess possible development of reinfections and re-positivity. Methods During a 6-month period, 202 PCR-confirmed recovering COVID-19 patients entered this study. Follow-up RT-PCR tests and symptom assessment were performed 1 month after the initial positive results. Patients who tested negative were tested again 1 and 3 months later. The serum IgG and IgM levels were measured in the last follow-up session. Results In the first two follow-up sessions, 82 patients continued their participation, of which four patients tested positive. In the second follow-up 44 patients participated, three of whom tested positive. None of the patients who tested positive in the first and second follow-up session were symptomatic. In the last session, 32 patients were tested and four patients were positive, three of them were mildly symptomatic and all of them were positive for IgG. Conclusions A positive RT-PCR in a recovering patient may represent reinfection. While we did not have the resources to prove reinfection by genetic sequencing of the infective viruses, we believe presence of mild symptoms in the three patients who tested positive over 100 days after becoming asymptomatic, can be diagnosed as reinfection. The immune response developed during the first episode of infection (e.g., IgG or T-cell mediated responses that were not measured in our study) may have abated the symptoms of the reinfection, without providing complete protection.Keywords
This publication has 36 references indexed in Scilit:
- False negative rate of COVID-19 is eliminated by using nasal swab testTravel Medicine and Infectious Disease, 2020
- Variant analysis of SARS-CoV-2 genomesBulletin of the World Health Organization, 2020
- Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivationJournal of Infection, 2020
- Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019Clinical Infectious Diseases, 2020
- The outbreak of SARS-CoV-2 pneumonia calls for viral vaccinesnpj Vaccines, 2020
- Rescue of premature aging defects in Cockayne syndrome stem cells by CRISPR/Cas9-mediated gene correctionProtein & Cell, 2019
- Persistence of Antibodies against Middle East Respiratory Syndrome CoronavirusEmerging Infectious Diseases, 2016
- Correlates of Protection Induced by VaccinationClinical and Vaccine Immunology, 2010
- Duration of Humoral Immunity to Common Viral and Vaccine AntigensNew England Journal of Medicine, 2007
- Longitudinal profile of antibodies against SARS‐coronavirus in SARS patients and their clinical significanceRespirology, 2006